NASDAQ: INO · Biotechnology
Over the past week, Inovio Pharmaceuticals (INO) pulled in about 30 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 20% bullish but is deeply split: X runs 53% bullish while Reddit sits at just 0%. Wall Street is more constructive, with 1 of 3 analysts rating INO a buy.
There is little buzz around INO this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 33% buy share sits next to a crowd that ranges from Reddit at 0% to X at 53%. No other tracker puts the two side by side.
Across 3 analysts the consensus is a Hold: 1 buy call against 0 sell, with an average 12-month price target of $2.77.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is mixed and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 13 points above the crowd average of 20%, the professionals are more constructive than retail. The split is inside the crowd: X reads 53% bullish while Reddit sits at 0%, a 53-point spread that single-source trackers miss.
Over the 30-day window, Inovio Pharmaceuticals (INO) buzz held subdued around 34.4 while the price drifted down 2.7% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 5.5M shares. Updated Aug 15, 2026. Over the last 7 trading days, INO gained 61.8%. Buzz activity in the recent week averaged 35.2 and was relatively stable, swinging between 24.8 and 44.3. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment split evenly between bullish and bearish days, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for INO and 2000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live INO sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 15, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Hold (1 / 2 / 0) |
| Crowd bullish (7d) | 20% |
| Avg price target | $2.77 |
| Most bullish source | X, 53% |
| Most bearish source | Reddit, 0% |
| Sentiment spread | 53 pts |
| Mentions (7d) | 30 |
| Market cap | $112.6M |
| P/E · Forward P/E | n/a · 16.6 |
| EPS · Beta | -$1.03 · 1.5 |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Inovio Pharmaceuticals (INO) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 20% bullish across 3 active sources. Those sources contribute 30 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Inovio Pharmaceuticals (INO) is fairly quiet with 0 mentions over the last 7 days; the 30-day context spans 2 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Inovio Pharmaceuticals (INO), averaging 20% bullish across 3 tracked sources over the last 7 days. The two ends of the range are X at 53% bullish and Reddit at 0%, a 53-point spread. On the professional side, 1 of 3 analysts rate INO a buy.
Of the 3 analysts covering Inovio Pharmaceuticals (INO), 1 rate it a buy, 2 a hold and 0 a sell, for a hold consensus. The average price target is $2.77. That puts the street ahead of the crowd, which averages 20% bullish.
Inovio Pharmaceuticals (INO)'s cross-source average is bearish at 20% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. X reads 53% bullish, News reads 8% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Inovio Pharmaceuticals (INO) at 20% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. The most bearish reading is reddit at 0% bullish. 3-day activity momentum is falling on X, while news activity is rising. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 17 mentions (57% of total volume). News contributes 13 mentions. The cross-source average is bearish at 20% bullish, while news is the only source with rising 3-day activity. Source readings are split: 1 source leans bullish and 2 sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. INO's sell signal at 93/100 conviction reflects a bearish cross-source average at 20% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. It is a research shortcut, not financial advice.
The INO sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key